KCK Ltd.
- SEC CIK
- 0001657662
- Latest filing
- Oct 14, 2025
RNTX holding history
Rein Therapeutics, Inc. in every 13F filed by KCK Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RNTX overviewAll 13F holders of RNTXFull Q3 2025 holdings
- Shares (Q3 2025)
- 22,341
- Value
- $52.1K
- % of portfolio
- 0.3%
- Quarters held
- 12
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 22,341 | $52.1K | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2025 | 22,341 | – | – | 00.0% | Unchanged | Holders |
| Q1 2025 | 22,341 | $39.5K | 0.4% | 00.0% | Unchanged | Holders |
| Q4 2024 | 22,341 | $51.4K | 0.1% | – | No prior filing | Holders |
| Q4 2023 | – | – | – | – | Not filed | Holders |
| Q3 2023 | 22,341 | $34.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 22,341 | $40.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 22,341 | $27.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 22,341 | $52.9K | 0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | Holders |
| Q3 2022 | 446,817 | $101.0K | 0.2% | −200,000−30.9% | Reduced | Holders |
| Q2 2022 | 646,817 | $168.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2022 | 646,817 | $331.0K | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2021 | 646,817 | $362.0K | 0.3% | – | No prior filing | Holders |